Browse all practice questions for the Cohort Studies Practice Test. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Cohort Studies Practice Test course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • Which statement correctly describes censoring and right-censoring in cohort studies?
  • Which data sources are commonly used for cohort studies, and what is a typical strength?
  • The Primary Outcome in a study is defined as which of the following?
  • In cohort studies, risk ratio is preferred over odds ratio when which condition is met?
  • Which statement best reflects ethical considerations in cohort studies?
  • Outcome Types in cohort studies typically include which of the following?
  • What is the Cox proportional hazards assumption, and how can you assess it?
  • How is the incidence rate calculated from data with person-time?
  • Which statement correctly defines incidence rate?
  • What is effect modification in a cohort study?
  • How can sensitivity analyses assess the potential impact of unmeasured confounding in a cohort study?
  • End of Follow-up Criteria include which of the following?
  • Distinguish confounding from effect modification.
  • If RR equals 1 for a negative outcome, what does this indicate about the association?
  • Which statement about incidence proportion versus incidence rate is correct?
  • If RR equals 1, what does that imply?
  • According to the study design principles, which approach helps minimize loss to follow-up?
  • Which statement is true when discussing RR for a negative outcome?
  • Subgroup analyses are used to identify what?
  • Duration & Timing: which factors matter when evaluating exposure duration?
  • For a positive outcome such as recovery, an RR of 0.9 implies:
  • Differentiate interval censoring from right censoring and its analysis implications.
  • Distinguish open (dynamic) and closed (fixed) cohorts and discuss implications for analysis.
  • Why is temporal sequence between exposure and outcome essential in cohort studies?
  • The domain 'follow-up' in sensitivity analysis is used to assess the impact of what on results?
  • Loss to follow-up in a cohort study can lead to which issue?
  • In epidemiology, the E-value is best described as:
  • Immortal time bias in a cohort study occurs when a period during which the outcome could not occur is misclassified as exposed time. This bias most directly leads to which effect on the observed risk in the exposed group?
  • Which statement is true about RR values for a negative outcome?
  • What is a hazard ratio and in what model is it commonly estimated?
  • What is a pitfall of overly strict inclusion criteria?
  • Interpret relative risk in a cohort study and state its null value.
  • Which of the following is a long-term outcome example?
  • What is the primary purpose of stratified analysis in detecting effect modification?
  • The Index Date in a cohort study is typically defined as the date of cohort entry based on which event?
  • Which statement best describes survivor bias in this context?
  • In sensitivity analyses for cohort studies, which of the following is a typical approach?
  • Which of the following is NOT an essential step in critically appraising a cohort study?
  • If a 95% CI for relative risk includes 1, what does this imply about statistical significance at the 0.05 level?
  • Which statement best describes the core features of a cohort study?
  • Which statement correctly matches the measure to its typical interpretation in cohort data?
  • What is the role of negative controls in cohort studies?
  • Which reporting guideline is commonly used for cohort studies?
  • Which formula correctly computes the risk ratio from a 2x2 table?
  • Which item is included as a sensitivity analysis domain?
  • What is detection bias in a cohort study, and when does it occur?
  • Which of the following is a typical example of a short-term outcome?
  • Which statement best describes data collection in a prospective cohort study?
  • Identify a common error in interpreting cohort results, such as confusing odds ratio with risk ratio in rare outcomes.
  • What is selection bias in a cohort study and how can it arise?
  • How can effect modification be detected in analyses?
  • Which statement best describes immortal time bias in cohort studies?
  • In an open (dynamic) cohort, how are entries of new participants typically treated in analysis?
  • If a research question concerns cancer incidence after an exposure, which type of outcome should be prioritized?
  • What exposure are we interested in?
  • What is a hazard ratio, and how does it differ from a risk ratio in cohort data?
  • Which of the following is a disadvantage of cohort studies?
  • What is the risk of overmatching and when should matching be avoided?
  • What is confounding by indication, and is it a concern in observational cohort studies?
  • Which statement best captures the appropriate interpretation when the outcome direction matters (positive vs negative)?
  • In population attributable risk, which statement is correct?
  • Which population characteristics are commonly considered when defining the study population?
  • What is a nested cohort (nested case-control) study?
  • The two-by-two table is used to organize which categories?
  • Bias control in cohort studies can be achieved by which approach?
  • Can you compute number needed to treat (NNT) in a cohort study, and what information is required?
  • Kaplan-Meier curves are used to what purpose in cohort studies?
  • Differentiate nondifferential from differential misclassification and its impact on bias in cohort studies.
  • What is the primary purpose of a cohort study?
  • What is the purpose of the cumulative incidence function in the presence of competing risks?
  • Open (dynamic) cohorts are characterized by which of the following?
  • Which measure is most appropriate when follow-up times vary across participants?
  • A retrospective cohort study is characterized by which timeline?
  • What is the proportional hazards assumption in Cox models?
  • Exposure misclassification bias in a cohort study can bias results in which way?
  • What are the common measures of association in cohort studies?
  • Which statement accurately differentiates prospective and retrospective cohort studies?
  • What is an advantage of cohort studies regarding temporality?
  • Which approach specifically helps prevent immortal time bias in the analysis?
  • What data quality issues are most common in cohort studies, and how can they be mitigated?
  • What does generalizability in a cohort study primarily aim to reflect?
  • In survival analysis, informative censoring occurs when the reason for censoring is related to the risk of the event, which can bias hazard ratio estimates.
  • What is an advantage of cohort designs?
  • New User Design includes which group?
  • The interpretation of relative risk depends on whether the outcome is positive or negative. Which statement best reflects this caveat?
  • Incidence rate is often expressed per which unit of time?
  • In cohort data analysis, which scenario best motivates using Poisson regression rather than Cox regression?
  • Define confounding in a cohort study and provide an example.
  • In a two-by-two table, which cell corresponds to Exposed and Disease?
  • Which statement is true about bias in cohort studies compared to case-control studies?
  • In a hypothetical cohort study, 150/500 exposed develop the outcome vs 75/600 unexposed; compute RR and risk difference.
  • Which bias is less likely in a prospective cohort study because exposure is defined before outcome measurement?
  • Which statement about nondifferential misclassification is true?
  • If the study population does not reflect the clinical population, which bias increases?
  • Which statement best describes how censoring is handled in survival analysis?
  • Which statement best captures the scope of outcomes in a cohort study?
  • Compare p-values and confidence intervals in interpreting cohort study findings.
  • What are key sample size considerations for a cohort study?
  • To avoid confounding in a cohort study, what practice is recommended?
  • How should missing data be handled in cohort studies?
  • Which of the following factors influences statistical power in a cohort study?
  • Which method involves estimating effects within levels of a confounder to assess consistency of the exposure effect?
  • Which is a common bias in cohort studies?
  • Which statement best defines a cohort study and distinguishes prospective from retrospective designs?
  • Which of the following statements describes a limitation of using medical data registries in cohort studies?
  • Which data source is NOT a common source for exposure and outcome in cohort studies?
  • What does a cohort study typically compare?
  • What does a significant log-rank test indicate when comparing survival curves?
  • Which describes the New User Design?
  • In a study, an RR of 1.0 for a negative outcome indicates which of the following?
  • Why is loss to follow-up a potential source of bias in cohort studies?
  • Why is a nested case-control design often used within an existing cohort?
  • Provide an example of a classic cohort study.
  • Which statement best captures the RR interpretation caveat regarding outcome type?
  • Which stratification and multivariable adjustment methods help control confounding in cohort data?
  • Explain immortal time bias in cohort studies and provide a remedy.
  • What is the purpose of inclusion and exclusion criteria in study design?
  • In a cohort study, under what condition does the odds ratio approximate the relative risk?
  • How do time-varying exposures and covariates complicate analysis in cohort studies?
  • Sensitivity Analyses in cohort studies are used to?
  • What is the benefit of a nested case-control design within a cohort?
  • What is a new-user design and why is it used in observational cohort studies?
  • The formula RR = (a/(a+b)) ÷ (c/(c+d)) represents what?
  • Which metric expresses the relative instantaneous risk between two groups in survival analysis?
  • What is the primary interpretation of a hazard ratio of 2.0 in a survival comparison?
  • Core features of cohort studies include which combination?
  • How does precise specification of the source population and eligibility criteria affect internal validity?
  • How should confidence intervals be interpreted for relative risk?
  • A relative risk greater than 1 indicates what?
  • In cohort studies, what differentiates the induction period from the latency period, and why does it matter?
  • Why is clearly defining exposure important in cohort studies?
  • In a two-by-two table, which cell denotes Unexposed and No Disease?
  • Which statement best describes interval censoring in survival analysis?
  • Which statement about Poisson regression is true in the context of cohort studies?
  • What is overmatching and how can it harm a cohort study?
  • How should a cohort study select an appropriate comparison group?
  • Which statement best reflects the interpretation of RR across outcomes?
  • Differentiate between attrition and loss to follow-up; how can attrition bias affect results?
  • Which statement best describes end-of-follow-up criteria in a cohort study?
  • What is the purpose of using a time-dependent Cox model in cohort studies?
  • What does transportability refer to in cohort studies?
  • Which data source is commonly used to capture long-term health outcomes in cohort studies?
  • What is the purpose of sensitivity analysis?
  • What is incidence rate (incidence density) and how is it calculated?
  • What is attributable risk?
  • What fundamental temporal relationship does a cohort study establish between exposure and outcome?
  • Long-Term Outcomes are best described as measurements taken over which time frame?
  • Define population-attributable risk (PAR) and how is it calculated?
  • If RR equals 1, what does this imply about the relationship between exposure and the outcome?
  • How would you test for effect modification by age when studying a drug exposure and an outcome in a cohort?
  • If sensitivity analysis shows changing results, what does that imply?
  • What is person-time and how is it used to compute incidence rate?
  • What is the primary purpose of detailing population characteristics such as age, sex, and comorbidities?
  • How do you compute person-time and why is it used for incidence rate calculations?
  • In cohort studies, a Competing Risk refers to what concept?
  • In cohort studies, what type of bias results from misclassification of exposure or outcome data?
  • What is the purpose of a washout period in cohort exposure definitions?
  • In a cohort study, the Index Date is defined as what?
  • What is a key limitation of the Prevalent User Design?
  • Which statement best describes external validity in a cohort study?
  • Which design is more likely to reflect real-world practice?
  • What does a retrospective cohort study involve?
  • Prevalent User Design is most associated with which characteristic?
  • Which data source combination is described as having strengths of detail and large samples but potential misclassification and missing data?
  • Which approach is cited for handling missing data in cohort studies?
  • Which statement correctly describes open (dynamic) cohorts?
  • Why is defining the outcome important in a cohort study?
  • If RR is 0.6 for developing a disease, what is the percent reduction in risk for the exposed group?
  • What is cumulative incidence and how is it calculated?
  • Which statement correctly distinguishes risk from incidence rate?
  • What is the healthy worker effect and how can it bias cohort results?
  • In the numerator of the relative risk, the incidence in the exposed group is which expression?
  • What strategies can reduce confounding at the design stage of a cohort study?
  • How does a nested case-control within a cohort optimize resource use for rare outcomes?
  • What is a potential downside of applying overly strict inclusion and exclusion criteria in a study?
  • Which ethical considerations are essential regarding privacy and data use in cohort studies?
  • Differential vs nondifferential outcome misclassification: which statement is correct?
  • Which method is commonly used to compare survival curves between groups?
  • Differential outcome misclassification can bias study results in which ways?
  • Which statement best describes the relationship between exposure and disease status in the two-by-two table cells a and c?
  • Why distinguish specific drug vs drug class in exposure measurement?
  • What does the number needed to treat (NNT) represent in a cohort study?
  • Why is self-reported exposure data a concern in cohort studies?
  • What is left truncation (delayed entry) in survival analysis, and when is it used in cohort studies?
  • Which bias refers to systematic misclassification of exposure or outcome?
  • Distinguish selection bias from information bias in a cohort study and provide an example.
  • If an exposure reduces the risk of an adverse event, which statement is accurate?
  • What strategy helps reduce bias from prior drug use when studying new users?
  • What is meant by 'person-time at risk' in cohort studies?
  • Which statement best describes why Kaplan-Meier curves do not inherently adjust for covariates?
  • Which elements define the core research question components in a cohort study?
  • What is censoring in survival analysis, and what is right-censoring?
  • When effect modification is present, how is it typically reported?
  • Composite Outcomes are defined as?
  • Exposure measurement should include which factors?
  • How can case ascertainment bias arise in a cohort, and how can it be mitigated?
  • Relative risk is defined as?
  • Why is the risk difference particularly informative for public health planning?
  • Why is latency an important consideration in duration-timing assessment?
  • Why is loss to follow-up problematic in cohort studies, and how can you address it?
  • What is the role of the comparison group in a cohort study?
  • What information does a Kaplan-Meier curve provide in a cohort study, and what are its limitations?
  • Bias control in cohort studies can be achieved by which approach?
  • Which scenario would indicate no difference in risk between exposed and unexposed groups?
  • Which method adequately handles time-varying exposures in a cohort study?
  • What are competing risks and how do they affect cohort analyses?
  • Which approach helps minimize loss to follow-up?
  • Which domain is used to handle data gaps during sensitivity analysis?
  • How is the study population typically defined in cohort research?
  • Which statement best describes non-differential misclassification of exposure?
  • Which of the following is considered a Hill criterion for causality in cohort studies?
  • What are competing risks, and how do they affect interpretation of incidence in a cohort?
  • Cohort vs Experimental: A cohort study is best described as?
  • Secondary Outcomes are best described as what?
  • What is the purpose of inverse probability weighting in cohort studies?
  • Which is true about RR values when describing a protective effect for a negative outcome?
  • How does start time and immortal time bias relate to exposure definition?
  • What is the risk of ecological fallacy in cohort studies using group-level data?
  • Which method assesses unmeasured confounding that could explain away an observed association?
  • Attrition bias in cohort studies refers to bias from differential loss to follow-up. Which mitigation strategies are commonly employed?
  • In time-to-event analysis using Cox regression, what is the role of censoring?
  • How do you interpret a 95% confidence interval for a risk ratio?
  • What is the purpose of a proportional hazards (Cox) model in cohort data?
  • How can confounding be controlled in cohort studies?
  • What are common ancillary analyses in cohort studies to test robustness?
  • In a cohort study, which comparison best reflects how risk is assessed?
  • What does the risk difference represent?
  • Why is adequate follow-up important in cohort studies?
  • Which statement correctly distinguishes prospective from retrospective cohort designs?
  • Define cumulative incidence.
  • Which method can address non-random informative censoring in survival analyses?
  • If the relative risk is less than 1 for a negative health outcome, what does this indicate about risk in the exposed group?
  • External validity, or generalizability, in cohort studies depends on which aspects?
  • Which method is used to control confounding in the design phase of a cohort study?
  • What practice helps prevent measurement bias in data collection?
  • Which models are commonly used to analyze time-to-event data in cohort studies?
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy